Absence of SARS-CoV-2 infections among patients with end-stage renal disease following facility-wide testing in four outpatient hemodialysis facilities

Am J Infect Control. 2021 Oct;49(10):1318-1321. doi: 10.1016/j.ajic.2021.07.022. Epub 2021 Aug 8.

Abstract

Facility-wide testing performed at 4 outpatient hemodialysis facilities in the absence of an outbreak or escalating community incidence did not identify new SARS-CoV-2 infections and illustrated key logistical considerations essential to successful implementation of SARS-CoV-2 screening. Facilities could consider prioritizing facility-wide SARS-CoV-2 testing during suspicion of an outbreak in the facility or escalating community spread without robust infection control strategies in place. Being prepared to address operational considerations will enhance implementation of facility-wide testing in the outpatient dialysis setting.

Keywords: COVID-19; End-Stage Renal Disease; Facility-wide testing SARS-CoV-2; Hemodialysis.

MeSH terms

  • COVID-19 Testing
  • COVID-19*
  • Humans
  • Kidney Failure, Chronic*
  • Outpatients
  • Renal Dialysis / adverse effects
  • SARS-CoV-2